These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 19142702)
1. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease. Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702 [TBL] [Abstract][Full Text] [Related]
2. Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine. Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K J Nucl Med; 2005 Jan; 46(1):32-7. PubMed ID: 15632030 [TBL] [Abstract][Full Text] [Related]
3. Increased Binding Potential of Brain Adenosine A Hayashi S; Inaji M; Nariai T; Oda K; Sakata M; Toyohara J; Ishii K; Ishiwata K; Maehara T J Neurotrauma; 2018 Jan; 35(1):25-31. PubMed ID: 28728462 [TBL] [Abstract][Full Text] [Related]
4. Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX. Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K Ann Nucl Med; 2003 Sep; 17(6):511-5. PubMed ID: 14575390 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine. Kimura Y; Ishii K; Fukumitsu N; Oda K; Sasaki T; Kawamura K; Ishiwata K Nucl Med Biol; 2004 Nov; 31(8):975-81. PubMed ID: 15607479 [TBL] [Abstract][Full Text] [Related]
6. Adenosine A Mishina M; Ishii K; Kimura Y; Suzuki M; Kitamura S; Ishibashi K; Sakata M; Oda K; Kobayashi S; Kimura K; Ishiwata K Synapse; 2017 Aug; 71(8):. PubMed ID: 28407307 [TBL] [Abstract][Full Text] [Related]
7. Age-Related Decrease in Male Extra-Striatal Adenosine A Mishina M; Kimura Y; Sakata M; Ishii K; Oda K; Toyohara J; Kimura K; Ishiwata K Front Pharmacol; 2017; 8():903. PubMed ID: 29326588 [TBL] [Abstract][Full Text] [Related]
8. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246 [TBL] [Abstract][Full Text] [Related]
9. Use of 11C-MPDX and PET to study adenosine A1 receptor occupancy by nonradioactive agonists and antagonists. Paul S; Khanapur S; Sijbesma JW; Ishiwata K; Elsinga PH; Meerlo P; Dierckx RA; van Waarde A J Nucl Med; 2014 Feb; 55(2):315-20. PubMed ID: 24434292 [TBL] [Abstract][Full Text] [Related]
10. Increased adenosine A1 receptor levels in hemianopia patients after cerebral injury: an application of PET using 11C-8-dicyclopropylmethyl-1-methyl-3-propylxanthine. Suzuki Y; Nariai T; Kiyosawa M; Mochizuki M; Kimura Y; Oda K; Ishii K; Ishiwata K Clin Nucl Med; 2012 Dec; 37(12):1146-51. PubMed ID: 23154471 [TBL] [Abstract][Full Text] [Related]
11. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria. Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634 [TBL] [Abstract][Full Text] [Related]
12. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034 [TBL] [Abstract][Full Text] [Related]
13. Small-animal PET study of adenosine A(1) receptors in rat brain: blocking receptors and raising extracellular adenosine. Paul S; Khanapur S; Rybczynska AA; Kwizera C; Sijbesma JW; Ishiwata K; Willemsen AT; Elsinga PH; Dierckx RA; van Waarde A J Nucl Med; 2011 Aug; 52(8):1293-300. PubMed ID: 21764782 [TBL] [Abstract][Full Text] [Related]
14. PET imaging of adenosine A(1) receptors with (11)C-MPDX as an indicator of severe cerebral ischemic insult. Nariai T; Shimada Y; Ishiwata K; Nagaoka T; Shimada J; Kuroiwa T; Ono K; Ohno K; Hirakawa K; Senda M J Nucl Med; 2003 Nov; 44(11):1839-44. PubMed ID: 14602868 [TBL] [Abstract][Full Text] [Related]
15. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Mosconi L Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152 [TBL] [Abstract][Full Text] [Related]
16. Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography. Ishiwata K; Nariai T; Kimura Y; Oda K; Kawamura K; Ishii K; Senda M; Wakabayashi S; Shimada J Ann Nucl Med; 2002 Sep; 16(6):377-82. PubMed ID: 12416575 [TBL] [Abstract][Full Text] [Related]
17. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease. Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943 [TBL] [Abstract][Full Text] [Related]
18. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517 [TBL] [Abstract][Full Text] [Related]
19. First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX. Ishiwata K; Mishina M; Kimura Y; Oda K; Sasaki T; Ishii K Synapse; 2005 Feb; 55(2):133-6. PubMed ID: 15543628 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]